✦ LIBER ✦

Management of the non-descended testis: doubtful value of luteinizing-hormone-releasing-hormone (LHRH). A double-blind, placebo-controlled multicentre study

✍ Scribed by L. H. OLSEN; H. G. GENSTER; A. MOSEGAARD; F. S. JØRGENSEN; N. HOFMAN; V. B. JENSEN; L. B. LASSEN; M. RASSMUSSEN; L. VINZENTS; L. DAMMEGAARD; S. MUNCK; K. BRÖNDUM-NIELSEN

Book ID: 114730435
Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 702 KB
Volume: 15
Category: Article
ISSN: 0105-6263
DOI: 10.1111/j.1365-2605.1992.tb01122.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind, placebo-controlled study o

Double-blind, placebo-controlled study of luteinising-hormone-releasing-hormone nasal spray in the treatment of undescended testes: S.M.P.F. De Muinck Keizer-Schrama, F.W.J. Hazebroek, A.W. Matroos, et al. Lancet i:876–879, (April 19), 1986

✍ Prem Puri 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Recombinant Luteinizing Hormone (rLH) In

Recombinant Luteinizing Hormone (rLH) Induces Ovarian Angiogenesis In Vivo via Modulation of the Expression of Follicular Vascular Endothelial Growth Factor (VEGF)-A165 and Its Soluble Receptor sFlt-1/VEGFR-1 but not Placental Growth Factor (PlGF). A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

✍ G. Gutman; V. Barak; S. Maslovitz; A. Amit; J.B. Lessing; E. Geva 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 80 KB